HAPLN1 and Miyoshi myopathy: We further showed in MM cancer cells that the PTR1 domain of HAPLN1 (HAPLN1-PTR1), but not full-length protein, activated the transcription factor NF-κB, a mediator of inflammation and cell survival that has been implicated in cancer progression.